NOACs May Be Better Choice for Patients With A-Fib and DM

MONDAY, Feb. 14, 2022 -- For patients with atrial fibrillation (AF) and diabetes mellitus (DM), non-vitamin K antagonist oral anticoagulants (NOACs) are associated with lower risks for diabetes complications and mortality than warfarin, according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news